Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Tilray Brands

Village Farms International

Investors looking to capitalize on the growing cannabis market should watch top Canadian marijuana stocks this week. With the US cannabis industry projected to reach $41 billion by 2025, many Canadian companies are expanding their presence across the border. This expansion is driven by increasing legalization efforts and growing consumer demand. For example, recent news highlights the potential for federal legalization in the US, which could open up significant opportunities for Canadian companies. Investors should utilize technical analysis and proper risk management strategies to navigate this dynamic market. Analyzing price trends, volume, and support levels can provide valuable insights into potential stock movements.

Best Canadian Cannabis Stocks to Watch in September

Aurora Cannabis

Cronos Group

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

Switch to Vaporizing and Try the VENTY TUTTLINGEN, Germany , Aug. 29, 2024 /PRNewswire/ - STORZ & BICKEL GmbH (" STORZ & BICKEL "), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), today announced the launch of a new inaugural campaign, the Smokeless September Challenge. This initiative invites consumers to take a break from combustion throughout September and experience the advantages of vaporizing with STORZ & BICKEL's latest device, the VENTY.

STORZ & BICKEL Debuts Inaugural "Smokeless September Challenge" to Educate Consumers on the Advantages of Vaporization

Curaleaf Holdings, Inc.

Cannabis stocks have crashed hard this year as concerns about the industry continued. The AdvisorShares Pure US Cannabis ETF (MSOS) stock has plunged by almost 14% this year and is down by over 46% from its highest point this year.

Here's why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed

Canopy Growth CEO David Klein will retire at the end of the company's current fiscal year. While he has helped bring down expenses, profitability remains a big problem for the business.

Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?

Cannabis stocks slumped Tuesday after the Drug Enforcement Administration (DEA) announced a hearing that could reclassify marijuana as a less harmful, Schedule III drug won't come until Dec. 2—after the 2024 presidential election.

Cannabis Stocks Slide as DEA Sets Post-Election Marijuana Hearing in December

The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.

3 Weed Stocks Sinking on Reclassification Hearing Update

SNDL Inc.

The Canadian cannabis sector continues attracting attention from investors, especially as the US market shows promising growth. With over 39 states having legalized cannabis in some form, the US cannabis industry is projected to reach $100 billion by 2030. This rapid expansion presents a unique opportunity for Canadian companies with significant US operations. Recently, headlines have highlighted the push for federal legalization in the US, sparking renewed interest in marijuana stocks. Investors are mainly focused on Canadian companies, as they are well-positioned to capitalize on any positive legislative changes in the US.

Top Canadian Cannabis Stocks to Watch Before September

Aurora Cannabis and Canopy Growth have been leading companies within the cannabis industry for years. Both businesses have struggled, however, and have been working on improving their financials.

Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years

The Canadian cannabis market continues to play a pivotal role in the North American cannabis industry. As US cannabis laws evolve, Canadian companies are well-positioned to capitalize on this growth. The US cannabis industry is expected to reach $45.9 billion by 2025, driven by increased legalization and consumer demand. Recent headlines have highlighted ongoing discussions in Congress about federal legalization, which could be a game-changer. With more states moving toward legalization, the market is ripe for expansion. Canadian cannabis stocks are gaining attention as investors look for opportunities in this growing sector. These stocks offer exposure to the Canadian market and the potential US boom.

Top Canadian Cannabis Stocks to Watch Now: High-Growth Opportunities in 2024

What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by day.

3 Of Today's Top Canadian Marijuana Stock Picks For Investors

Cannabis firm Canopy Growth said on Friday its CEO, David Klein, will retire at the end of the company's current fiscal year ending March 31, 2025.

Canopy Growth CEO to step down

David Klein, CEO to retire at the end of the Company's fiscal year Board of Directors expresses continued confidence in the Company's strategic direction and leadership team A comprehensive CEO selection process has been initiated to identify a successor This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated June 5, 2024. SMITHS FALLS, ON , Aug. 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that Mr.

Canopy Growth Announces CEO Succession Plan

Canopy Growth NASDAQ: CGC is one of the North American players in the cannabis industry. The company's shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated.

Canopy Growth Stock: Can It Sustain Recent Gains?

Canopy Growth's AGM to be held in a virtual-only format on Tuesday, September 24, 2024 at 1:00 PM ET. Voting is important and easy; shareholders are encouraged to vote now.

Canopy Growth Announces Mailing and Filing of Annual General Meeting Materials

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Earnings from North American cannabis companies for the second quarter have been a mixed bag, with expansion into new markets, operational streamlining, and product innovation key themes across the sector. Many multi-state operations (MSOs) are turning to emerging, less saturated international markets for growth, notably, Germany, which kicked off expanded medical sales amid broader legalization measures on April 1.

Cannabis MSOs embrace new markets, streamline operations in Q2

A new survey from cannabis telehealth platform NuggMD says most Americans buy their marijuana legally when they can. Ten percent of cannabis buyers still mostly buy from illegal sources.

Why Canopy Growth Stock Popped on Monday

Canopy Growth Corporation (CGC) shares dropped Friday after the company's first-quarter fiscal 2025 earnings fell significantly short of expectations.

Canopy Growth Stock Falls After Disappointing Earnings, Slowing Sales

Canopy Growth (NASDAQ: CGC ) is among the top Canada-based cannabis producers that investors are watching for clues on how the overall legal marijuana market is performing. Today's decline of more than 8% in CGC stock suggests continued weakness may be forthcoming.

Canopy Growth Stock News: What's Going On With CGC Stock Today?

Canopy Growth Corporation. (NASDAQ:CGC ) Q1 2025 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Michael Lavery - Piper Sandler William Kirk - Roth Capital Partners Operator Good morning.

Canopy Growth Corporation (CGC) Q1 2025 Earnings Call Transcript

The cannabis industry has experienced significant change since its inception twelve years ago.  Fueled by legalization trends and evolving social acceptance, this burgeoning sector has attracted considerable investment and innovation.

The Cannabis Sector: Profitability Takes Center Stage

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.40 per share a year ago.

Canopy Growth Corporation (CGC) Reports Q1 Loss, Lags Revenue Estimates

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) shares slipped almost 10% after it posted a widening loss for the fiscal first quarter and revenue fell short of expectations. The Smith Falls, Ontario-based cannabis producer posted a net loss of $127.1 million or C$1.60 per share, up from a loss of C$38.1 million of C$0.69 per share in the year-ago quarter.

Canopy Growth shares slump on widening quarterly loss, revenue miss

Canadian pot firm Canopy Growth reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis.

Canopy Growth posts smaller-than-expected core loss as costs drop

Canopy Growth Corp. CGC, +8.29% WEED, +7.60% said Friday its first-quarter loss widened to C$127.14 million ($92.7 million), or C$1.60 a share, from C$41.86 million, or C$0.69 a share in the year-ago quarter. Adjusted loss of C$1.63 a share fell short of the FactSet consensus estimate for a loss of 46 cents a share.

News for Canopy Growth Stock (CGC)